Science, Startup, Tech, Venture Capital, News.
Although I love working with founders and venture investing, I usually loathe writing about it. Most posts I read feel overdone and end up being reductionist to the point of low or no utility. Despite that, I felt the need to write about my most recent startup investment. The company, Recursion